In recent years, the ‘noise’ around the use of psychedelics and dissociatives to treat different neurological conditions (such as depression and PTSD) has been increasing. This potentially controversial treatment class has shaken up psychiatry and is becoming more mainstream within the therapeutic paradigm (such as the increase in ketamine clinics in the US). To explore the potential of this exciting treatment category, HRW Synapse, our team of neuroscience experts, interviewed a Key Opinion Leader and patient to explore the potential benefits and watchpoints of psychedelics and dissociatives from both the HCP and patient perspective, and conducted a friendly debate to discuss the potential of this category in this exclusive complimentary webinar titled ‘The Future of Psychiatry? A debate on Psychedelic and Dissociative Treatments’. If you wish to view this on-demand webinar, please contact m.mehmet@hrwhealthcare.com and include ‘HRW Synapse webinar recording’ in the subject line. Apply Now!